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Abstract
Background: The identification of circulating TB strains in the community and drug sensitivity patterns is essential
for the tuberculosis control program. This study was undertaken to identify M. tuberculosis strains circulating in
selected communities in Ethiopia as well as to evaluate the drug sensitivity pattern of these strains.
Method: This study was a continuation of the Ethiopian National TB Prevalence Survey that was conducted
between 2010 and 2011. Culture-positive isolates of M. tuberculosis from previous study were typed using region of
difference (RD) 9-based polymerase chain reaction (PCR) and spoligotyping. Drug sensitivity testing was conducted
using the indirect proportion method on Lowenstein-Jensen media.
Result: All 92 isolates were confirmed as M. tuberculosis by RD9-based PCR and spoligotyping of 91 of these
isolates leds to the identification of 41 spoligotype patterns. Spoligotype revealed higher diversity (45 %) and
among this 65.8 % (27/41) were not previously reported. The strains were grouped into 14 clusters consisting of
2–15 isolates. The dominant strains were SIT53, SIT149 and SIT37 consisting of 15, 11, and 9 isolates, respectively.
Our study reveals 70 % (64/91) clustered strains and only 39.1 % (25/64) occurred within the same Kebele. Further
assignment of the strains to the lineages showed that 74.7 % (68/91) belonged to Euro-American lineage, 18.6 %
(17/91) to East Africa Indian lineage and the remaining 6.5 % (6/91) belonged to Indo-oceanic lineage. Valid drug
susceptibility test results were available for 90 of the 92 isolates. Mono-resistance was observed in 27.7 % (25/90)
and poly-resistance in 5.5 % (5/90) of the isolates. Moreover, multi-drug resistance (MDR-TB) was detected in 4.4 %
of the isolates whilst the rest (60/90) were susceptible to all drugs. The highest level of mono-resistance, 26.6 %
(24/90), was observed for streptomycin with majority (91.1 %) of streptomycin mono-resistant strains belonging to
the Euro-American lineage.
Conclusion: In this study, the strains of M. tuberculosis circulating in selected sites of Ethiopia were identified along
with the drug sensitivity patterns. Thus, these findings are useful for the TB Control Program of the country.
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Background
There are an estimated 9 million new cases of TB every
year. TB is the second leading cause of death from an
infectious disease worldwide and is responsible for 1.5
million deaths annually. Control of TB is becoming a
challenge to the endemic countries due to the emergence
of drug resistance. Recently, the WHO Global TB Report
estimated that total of 480,000 people developed MDR-TB
worldwide in 2013. The prevalence of MDR-TB has been
estimated to be 3.5 % in newly diagnosed cases and 20.5 %
in previously treated TB cases [1].
In Ethiopia, TB is a major public health problem and the
WHO categorizes Ethiopia as a high TB and MDR-TB bur-
den country [1]. The first Ethiopian National TB prevalence
survey was conducted between 2010 and 2011. The preva-
lence of smear-positive TB among persons aged ≥ 15 years
was 108/100,000 (95 % CI 73–143), whereas the prevalence
of bacteriologically confirmed TB in the same age group
was 277/100,000 (95 % CI 208–347) [2]. According to the
nationwide drug resistance survey conducted between 2003
and 2005 the overall prevalence of MDR-TB was 2.5 %.
The prevalence of MDR-TB was 1.6 % and 11.8 % in newly
diagnosed TB cases and previously treated cases, respect-
ively [3].
Knowledge on the Mycobacterium tuberculosis (M.
tuberculosis) strains circulating in Ethiopian communities
and evaluation of the drug sensitivity patterns of these
strains is useful for the TB control program in the country.
Since the study was done on positive cultures isolated
from community-based survey, those patients who have
low health seeking behavior were mostly captured. There-
fore, this study was undertaken for the identification of
the M. tuberculosis strains circulating in selected commu-
nities in Ethiopia and thereafter to evaluate the drug sensi-
tivity pattern of these strains.
Methods
Study population
This study was a continuation of the Ethiopian National
TB Prevalence Survey that was conducted between 2010
and 2011. The participants for the prevalence survey
carried out by Kebede AH and colleagues were recruited
from 85 Kebeles (communes), selected from 85 Woredas
(districts) which were stratified as urban, rural and pas-
toralist population. The number of Kebeles covered in
rural, urban and pastoralist areas were 63, 14 and 8 re-
spectively. Sample size determination for the prevalence
survey is reported elsewhere [2]. The planned sample
size for prevalence survey was 46,514 adults aged ≥15
years. Following this 85 Woredas were selected by multi-
stage cluster sampling using probability proportion to
size (PPS) from three strata (urban, rural and pastoral-
ist). In each selected districts one Kebele with estimated
eligible adult of 548 was selected using PPS. However
during the recruitment of participants the total numbers
of individuals from 85 selected clusters were 51,667.
Since cluster sampling was used and to maximize sam-
ple size, all eligible individuals were invited to participate
in the study. Of the total eligible individuals, 46,697
(90 %) participated in the study. The case enrollments
for the study were based on symptoms suggestive of TB
(cough ≥2 weeks) and/or any abnormality in the lung
detected using chest X-ray. For individuals exempt from
chest X-ray who did not have cough ≥2 weeks, one of
the following criteria was used: weight loss >3 kg in the
last 1 month, night sweats >2 weeks, fever >2 weeks and
contact with a TB patient in the last year. Using the
above criteria a total of 6080 (13 %) participants were
eligible for sputum examination. Of these, 5868 (97 %)
submitted at least one sputum specimen and 5606
(92 %) submitted two specimens [2]. The present study
was carried out on culture positive isolates identified
from the prevalence survey.
Spatial distribution of the study sites at Woreda level
The spatial distributions of the selected study sites are
displayed at Woredas level (Fig. 1).
Laboratory tests
The laboratory analysis was carried out from July to
December 2012. For this study, deletion typing, spoloi-
gotyping and drug susceptibility testing were done on
positive isolates. Culture and identification of the isolates
for the prevalence survey were performed using 4 %
NaOH and Capilia test respectively.
Culture and identification
Equal amounts of 4 % NaOH were added to sputum in a
50 ml screw capped tube. The mixture was vortexed for
1–2 min and kept for 15 min at room temperature. Ster-
ile phosphate buffer (pH =6.8) was added up to 45 ml
and then centrifuged at 4 °C for 15 min at 3000 g. After
decanting the supernatant, a few drops of sterile phos-
phate buffer (pH =6.8) was added to reconstitute the
sediment. An aliquot of 100–200 μl of the sample sedi-
ment was then inoculated into two bottles of Löwen-
stein- Jensen (LJ) media. The inoculated media was
incubated at 37 °C. Bacterial growth was checked for
contamination and fast growers in first week and
followed weekly up to 8 weeks. Cultures with no growth
until the eighth weeks were recorded as negative [4].
Species identification was done for positive LJ cultures.
Identification of M. tuberculosis complex from other
mycobacterial species was performed using Capilia test.
The test is based on the M. tuberculosis antigen MPB64,
which is specific to the members of the M. tuberculosis
complex. Testing and interpretation of the assays was
done according to the manufacturer instruction [5].
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Molecular characterization of the isolates
Identification
Identification of M. tuberculosis from the other members of
the M. tuberculosis complex species was done using region
of difference (RD)-9 polymerase chain reaction. RD9-
PCRdeletion typing was performed on heat-killed cells to
confirm the presence or absence of RD9 using three
primers RD9flankF, RD9IntR and RD9flankR [6]. PCR amp-
lification was done as indicated by Berg et al. using a
commercially available kit (Qiagen, United Kingdom). Inter-
pretation of the result was based on differences in molecu-
lar weight. A molecular weight of 396bp was considered as
M. tuberculosis or M. canettii, while a molecular weight
575bp was considered M. bovis or M. africanum [7].
Molecular typing
Strain typing of M. tuberculosis was done using spoligo-
typing as previously described by Kamerbeek and col-
leagues [8]. The PCR amplification of DNA was done by
targeting the direct repeat (DR) locus, the region with
the highest level of polymorphism in the M. tuberculosis
chromosome. The DR region was amplified using primers
DRa (GGTTTTGGGTCTGACGAC) and DRb (CCGA
GAGGGGACGGAAAC). Spoligotyping was performed
with a commercially available kit according to the
manufacturer instructions (Isogen Bioscience BV Maarssen,
The Netherlands). Lineage and SIT (Shared International
Types) number assignment was done using SPOLD4 and
SPOTCLUST [9].
Drug Susceptibility testing
Drug susceptibility testing (DST) was performed for
first line drugs; isoniazid, streptomycin, rifampicin and
ethambutol, using indirect proportion method on Low-
enstein–Jense media. The critical concentration for
each drug was 0.2μg/ml, 4μg/ml, 40μg/ml and 2μg/ml
for isoniazid, streptomycin, rifampicin and ethambutol
respectively. Result interpretation was done by compar-
ing growth on control media and media containing
drug. If more than 1 % of the test population was ob-
served on the drug containing media, the result was
interpreted as resistant to that drug [10]
Fig. 1 Spatial distribution study sites at Woreda level
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Statistical analysis
Statistical analysis was carried out using SPSS software
packages. Patient characteristics for differences in pro-
portions were compared. The chi square test was used
to assess statistical significant difference. P values of 0.05
or less were regarded as significant.
Ethical consideration
The laboratory analysis was done on stored culture posi-
tive samples. Specific patient identifiers were not used
for this study. Ethical clearance was obtained from Sci-




The mean age of culture positive participants was 34.4
years (95 % CI 31.2–37.7). The overall culture positivity
rate was 1.6 % (96/5863). The distribution of culture
positivity across the categories of background character-
istics of TB suspects is summarized in Table 1. The cul-
ture positivity was significantly associated with age and
region of the study participants. High culture positivity
rate (3.2 %) was observed in age group between 15 and
24. Among three regions with high culture positivity rate
(Addis Ababa, SNNPR and Gambela) the contribution
of younger age categories (15–34) was 44 % (4 out of 9),
60 % (18 out of 30) and 80 % (4 out of 5) from the total
positive culture from those regions.
Molecular characterization of the isolates
Identification
Out of 96 isolates positive for M. tuberculosis complex
based on Capilia TB immunochromographic assay, 4 sam-
ples were excluded from RD9-PCR analysis (2 isolates failed
to grow after re-culturing and 2 cultures were not retrieved).
The remaining 92 isolates were analyzed based on region of
difference analysis. RD9 analysis showed that 92 isolates
contained an intact RD9. This indicated that the 92 isolates
were Mycobacterium tuberculosis species or M. canettii.
Molecular typing
Ninety two isolates were characterized using spoligotyp-
ing and 91 of them showed good patterns. Spoligotyping
identified 41 different spoligotypes with the overall di-
versity of 45 % and among this 65.8 % (27/41) were not
previously reported. The isolates were grouped into 14
clusters consisting of 2–15 isolates each. The dominant
strains of M. tuberculosis were SIT53 (15/91), SIT149
(11/91) and SIT37 (9/91). Our study reveals 70 % (64/
91) clustered strains of which 53 were registered in the
international database whereas 11 were newly identified.
Table 1 Culture result Vs sex, age, region and resident type
Culture Positive Culture Negative/NTM/Contaminated Total Culture Positivity Rate P-value
Sex Male 51 3122 3173 1.6 0.844
Female 45 2645 2690 1.7
Age 15–24 32 962 994 3.2 <0.001
25–34 21 1183 1204 1.7
35–44 17 1084 1101 1.5
45–54 12 992 1004 1.2
55–64 10 736 746 1.3
> = 65 4 810 814 0.5
Region Oromiya 28 2250 2278 1.2 <0.001
SNNPR 30 1191 1221 2.5
Amhara 10 948 958 1
Tigray 6 505 511 1.2
Afar 1 143 144 0.7
Gambela 5 83 88 5.7
Somali 7 388 395 1.8
Benshangul 0 25 25 0
Dire Dawa 0 45 45 0
Addis Ababa 9 189 198 4.5
Resident Urban 14 744 758 1.8 0.844
Rural 72 4349 4421 1.6
Pastoral 10 674 684 1.5
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Cluster formation within Kebeles was observed only
39.1 % (25/64) (Table 2). The proportion of Kebeles having
cluster isolates within the same Kebeles in urban, rural
and pastoralist were 28.5 % (4/14), 13.4 % (9/67) and
14.2 % (1/7) respectively. Geographic Information System
(GIS) mapping of cluster position of the strain showed
that clustering location was far apart (Fig. 2). Among 27
single strains 40.7 % were registered in the international
database. Further assignment of the strains to the lineages
showed that 74.7 % (68/91) belonged to Euro-American
lineage, 18.6 % (17/91) belonged to East Africa Indian
lineage and 6.5 % (6/91) to Indo-oceanic lineage.
Drug susceptibility test (DST)
Valid DST results for all first line anti-TB drugs were
available for 90 isolates (Table 3). Two isolates were ex-
cluded because of contamination. The drug susceptibility
pattern of the isolates revealed that 66.6 % (60/90) of the
isolates were susceptible to the four first-line drugs tested
(streptomycin, isoniazid, rifampicin and ethambutol).
Mono-resistance to any one of the four first line drugs
tested was found in 27.7 % (25/90) of the cases and poly-
resistance was found in 5.5 % (5/90) of cases. The highest
level of mono-resistance was observed for streptomycin
26.6 % (24/90). Of the 24 streptomycin mono-resistant
strain majority (91.1 %) belonged to the Euro-American
lineage and the rest belongs to Indo-oceanic lineage.
Multi-drug resistance (MDR) was detected in 4.4 % (4/90)
of the cases. The overall MDR-TB prevalence in national
survey conducted between 2003 and 2005 was 2.5 % [2].
The prevalence of MDR-TB did not show any significant
increase compared to the first round drug resistance sur-
vey conducted between 2003 and 2005 (P = 0.287). Among
the four MDR-TB detected, three of them were isolated
from young patients (age ranges 16–20). The lineage of
those MDR TB cases showed that three of them
belonged to East Africa Indian lineage and one
belonged to the Euro-American lineage.
Discussion
Tuberculosis (TB) is the most common opportunistic
infection in HIV positive patients and TB can occur at
any time during the course of HIV infection [11]. This
study’s findings showed high culture positivity among
the younger age groups and in three regions. The TB/
HIV sentinel report from 2010 to 2014 indicated that out
of those three regions, two regions ranked as the two most
HIV prevalent among TB patients (unpublished data),
which may account for the higher culture positivity rate in
younger age groups in those regions.
Most of human TB is caused by M. tuberculosis al-
though some cases are caused by M. bovis. In this study,
RD9deletion typing was used to differentiate between M.
bovis and M. tuberculosis [12, 13]. Even though most of
the isolates were collected in rural and pastoralist popula-
tion where raw milk consumption is widely practiced, all
the isolates obtained by this study were M. tuberculosis.
The absence of M. bovis among the isolates collected from
rural communities was unexpected and contradicts with
the earlier studies [14, 15]. The r absence of M. bovis re-
quires further study and may be due to the manifestation
of M. bovis in extra-pulmonary TB.
Cluster formation and epidemiological links have been
used to qualify recent transmission [16]. Our finding re-
veals clustering within same Kebele was low (39.1 %) even
without considering the parameters for making an epi-
demiological link. Since the larger portions of our samples
were collected from rural populations that were sparsely
populated, this might result in low rate of transmission as
a result clustering rate will be decreased, which is in line
with previous findings [16, 17]. Branden and colleagues
suggested that the transmission of common endemic
strains of M. tuberculosis occurs in relatively closed popula-
tions but in a rural setting the presence of clustering often
is not associated with recent transmission; it could be the
result of reactivation of remote infections acquired years or
decades earlier.
Understanding the prevalence of TB drug resistance
offers an opportunity to assess the extent of resistant
bacteria transmission in the community as well as evalu-
ate effect of the National Tuberculosis Program [18].
Table 2 Distribution of previously registered and newly
identified cluster in Kebeles
Same Kebele Different Kebele
SIT for previously registered strains Number (%) Number (%)
53 4 (26.7) 11 (73.3)
149 4 (36.4) 7 (63.6)
37 4 (44.4) 5 (55.6)
26 0 (0.0) 3 (100)
119 0 (0.0) 3 (100)
910 0 (0.0) 3 (100)
247 2 (66.7) 1 (33.3)
21 0 (0.0) 2 (100)
289 0 (0.0) 2 (100)
777 2 (100) 0 (0.0)
Sub Total 16 (30.2) 37 (69.8)
Newly identified strains
Orphan 2 (50.0) 2 (50.0)
Orphan 3 (100) 0 (0.0)
Orphan 2 (100) 0 (0.0)
Orphan 2 (100) 0 (0.0)
Sub Total 9 (81.8) 2 (18.2)
Total 25 (39.1 %) 39 (60.9 %)
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The MDR rate did not show any significant increment
compared to the previous nationwide surveillance re-
port even though the study population was different
[3]. A study conducted in the Philippines at hospitals in
Metro Manila, multi- drug resistant TB prevalence
rates in hospital ranged from 14–45 %, whereas the
community rate of MDR TB in Metro Manila was
6.4 % [19]. This suggested that high rate of MDR TB
occur in health facilities. Thus in Ethiopia, the rate of
MDR TB in the health facilities might be higher than
the finding of this current study. Out of 4 MDR cases
identified in the present study, three MDR TB cases oc-
curred in participants 16–20 years old. As reported by
another study [20] the high prevalence of primary
MDR-TB in a young population group implies trans-
mission of drug resistant strains.
Fig. 2 Distribution of strains in their respective collection sites at Woreda level: Both registered and orphan clustered strains were indicated in
colored. Orphans were given a number according to their order of identification. Both registered and orphan single isolates is represented in red
hallow circle. The numeral in the side of the circle indicates that the number of single strains identified in that specific location





INH only 1 1.1
SM only 24 26.6
INH + SM 1 1.1
MDR 4 4.4
INH + SM + RIF 1 1.1
INH + SM + RIF + EMB 3 3.3
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Conclusions
In this study, the strains of M. tuberculosis circulating in
selected sites of Ethiopia were identified along with the
drug sensitivity patterns. More than 83 % of the popula-
tion is living in rural areas of Ethiopia. Since declining
incidence of TB is expected with decreased clustering,
coupling case detection and treatment alone in those
large portions of the rural population will have a huge
contribution to the reduction of TB. Besides, TB and
MDR rate in young was high but with such small num-
ber of cases the possible relationship is inconclusive it
needs further study.
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